In LOAD2 mice on a high-fat diet, synapses go haywire even without Aβ plaques. ApoE-Christchurch variant bolsters protective ...

America's COVID celebrity is facing scrutiny for funding risky research that may have sparked the pandemic—and for allegedly ...

Monoclonal antibodies—treatments developed by cloning a cell that makes an antibody—could help provide an answer to the ...

Scientists in China have created a mutant strain of COVID-19 in a lab that has a 100% death rate for mice with human genes.

Using engineered mice, researchers developed monoclonal antibodies that were effective against infection with A. baumannii.

HIV-1 Vpu triggers the cleavage of TDP-43 by stimulating Caspase 3 activation. The cleavage products generated can induce the ...

Tangles of tau proteins in the brain are a hallmark of Alzheimer's disease, but recently, these crucial filaments have ...

Late-breaking data at WCLC show Libtayo monotherapy nearly doubled median overall survival and reduced the risks of death and disease progression ...

Following Priority Review, Dupixent is now available to patients as young as 12 years with inadequately controlled CRSwNPCurrent treatment ...

Tango Therapeutics is a high-risk, high-reward opportunity in the field of PRMT5-inhibitor drugs targeting MTAP-deleted ...